Cargando…
Hormone therapy in combination with radiotherapy in the treatment of prostate cancer: why and in which group of patients?
In recent years, significant development in the treatment of prostate cancer has taken place. One of the most documented methods of treatment in patients characterised by a high risk of progression is a combination of radiotherapy (RT) with long-term hormone therapy (HT). In this group of patients,...
Autores principales: | Milecki, Tomasz, Antczak, Andrzej, Kwias, Zbigniew, Milecki, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507889/ https://www.ncbi.nlm.nih.gov/pubmed/26199563 http://dx.doi.org/10.5114/wo.2015.50010 |
Ejemplares similares
-
Radiotherapy combined with hormonal therapy in prostate cancer: the state of the art
por: Milecki, Piotr, et al.
Publicado: (2010) -
The use of luteinizing hormone-releasing hormone analogues is still an indispensable element of therapy in castrate-resistant prostate cancer
por: Milecki, Tomasz, et al.
Publicado: (2014) -
Benefit of Whole Pelvic Radiotherapy Combined with Neoadjuvant Androgen Deprivation for the High-Risk Prostate Cancer
por: Milecki, Piotr, et al.
Publicado: (2009) -
What is the possible role of PSA doubling time (PSADT) and PSA velocity (PSAV) in the decision-making process to initiate salvage radiotherapy following radical prostatectomy in patients with prostate cancer?
por: Milecki, Piotr, et al.
Publicado: (2011) -
Polish Medical Students’ Knowledge Regarding Human Papillomavirus’s Ways of Transmission, Risk of Cancer Development and Vaccination, and Their Intention to Recommend Vaccination
por: Milecki, Tomasz, et al.
Publicado: (2021)